Clinic
Medalliance Medical Health Services INC
Medalliance Medical Health Services INC was paid $32.58M by Medicaid between Jan 2018 and Dec 2024, across 178 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoMEDALLIANCE MEDICAL HEALTH SERVICES INC
BRONX, NY 10458
BRONX, NY 10458
33aNPI1558356741assigned 09/14/2005
33bProvider typeClinic/Center
28Total paid$32.58M
24GClaims482,766
24DCodes billed178
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in New York
Rank by total paid#5 of 235
Median peer was paid$630K
This provider vs. median52×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 65,208 | $3.46M | |
| 2019 | 96,427 | $4.34M | |
| 2020 | 81,995 | $4.40M | |
| 2021 | 81,410 | $6.18M | |
| 2022 | 64,302 | $5.75M | |
| 2023 | 51,841 | $5.05M | |
| 2024incomplete | 41,583 | $3.40M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 106,091 | 86,713 | $8.95M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 39,782 | 33,843 | $4.46M |
| 36478 | 8.9% | 3,113 | 2,303 | $2.89M | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.2% | 16,348 | 15,721 | $1.69M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 3.3% | 20,800 | 7,242 | $1.08M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.5% | 27,139 | 10,369 | $808K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.5% | 4,094 | 4,073 | $803K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.4% | 6,108 | 5,924 | $769K |
| 20552 | 2.3% | 8,386 | 6,179 | $758K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 14,208 | 13,457 | $730K |
| 95819 | 2.0% | 3,154 | 3,102 | $641K | |
| 93970 | 1.7% | 5,328 | 5,233 | $555K |
166 more codes
| 97161 | 1.7% | 8,819 | $550K | |
| 11900 | 1.4% | 2,861 | $459K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.3% | 19,937 | $421K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.3% | 4,097 | $415K |
| 93351 | 1.0% | 1,590 | $331K | |
| 36475 | <1% | 277 | $322K | |
| 93880 | <1% | 3,040 | $313K | |
| 52000 | <1% | 286 | $302K | |
| 11102 | <1% | 1,096 | $290K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 4,030 | $289K |
| 17110 | <1% | 1,629 | $288K | |
| 20610 | <1% | 1,644 | $280K | |
| 93971 | <1% | 4,027 | $273K | |
| 92551 | <1% | 6,578 | $200K | |
| 95923 | <1% | 2,469 | $194K | |
| 93922 | <1% | 2,606 | $166K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,870 | $159K |
| 95708 | <1% | 629 | $142K | |
| 97014 | <1% | 12,085 | $132K | |
| 97164 | <1% | 2,398 | $130K | |
| 97010 | <1% | 7,363 | $126K | |
| 93923 | <1% | 1,076 | $125K | |
| 92546 | <1% | 2,121 | $124K | |
| 11056 | <1% | 795 | $122K | |
| 37225 | <1% | 13 | $107K | |
| 93886 | <1% | 890 | $107K | |
| 93925 | <1% | 1,040 | $103K | |
| 37229 | <1% | 18 | $103K | |
| 20553 | <1% | 1,068 | $102K | |
| 10040 | <1% | 439 | $98K | |
| 92537 | <1% | 1,851 | $92K | |
| 96132 | <1% | 1,325 | $90K | |
| 93924 | <1% | 789 | $89K | |
| 99205 | Prolong outpt/office vis | <1% | 632 | $82K |
| 92540 | <1% | 1,237 | $80K | |
| 95951 | <1% | 71 | $72K | |
| 93000 | <1% | 7,128 | $69K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 717 | $64K |
| Q3014 | Telehealth originating site facility fee | <1% | 3,723 | $62K |
| 11755 | <1% | 231 | $59K | |
| 93224 | <1% | 584 | $59K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,551 | $44K |
| 95921 | <1% | 387 | $43K | |
| 99385 | <1% | 368 | $38K | |
| 86328 | <1% | 1,660 | $35K | |
| 62323 | <1% | 254 | $33K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 869 | $29K |
| 64505 | <1% | 368 | $29K | |
| 97032 | <1% | 902 | $28K | |
| 99442 | <1% | 285 | $26K | |
| 99386 | <1% | 221 | $24K | |
| 11100 | <1% | 307 | $23K | |
| 11721 | <1% | 630 | $23K | |
| 31231 | <1% | 132 | $21K | |
| 92541 | <1% | 958 | $21K | |
| 96119 | <1% | 329 | $20K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 343 | $20K |
| 92545 | <1% | 1,022 | $19K | |
| 99243 | <1% | 221 | $19K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 114 | $18K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,396 | $18K |
| 92542 | <1% | 674 | $18K | |
| 99242 | <1% | 260 | $16K | |
| 51728 | <1% | 63 | $15K | |
| 95943 | <1% | 178 | $15K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 348 | $14K |
| 92544 | <1% | 673 | $12K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 575 | $12K |
| 99443 | <1% | 100 | $12K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 796 | $11K |
| 95953 | <1% | 62 | $11K | |
| 95910 | <1% | 99 | $10K | |
| 95700 | <1% | 90 | $10K | |
| 99173 | <1% | 4,907 | $10K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 94 | $8K |
| 36473 | <1% | 44 | $8K | |
| 95886 | <1% | 89 | $8K | |
| 20600 | <1% | 56 | $7K | |
| 90673 | <1% | 172 | $6K | |
| 95909 | <1% | 90 | $6K | |
| 95723 | <1% | 66 | $6K | |
| 95813 | <1% | 30 | $6K | |
| 99241 | <1% | 92 | $6K | |
| 96138 | <1% | 262 | $5K | |
| 96139 | <1% | 264 | $5K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 46 | $5K |
| 93229 | <1% | 12 | $5K | |
| 95812 | <1% | 30 | $4K | |
| 93040 | <1% | 488 | $4K | |
| 99441 | <1% | 62 | $4K | |
| 82948 | <1% | 1,094 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 116 | $4K |
| 76882 | <1% | 129 | $4K | |
| 93272 | <1% | 159 | $4K | |
| 90658 | <1% | 275 | $3K | |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | <1% | 97 | $3K |
| 0012A | <1% | 115 | $3K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 172 | $3K |
| 0011A | <1% | 108 | $3K | |
| 93270 | <1% | 160 | $3K | |
| 99072 | <1% | 9,387 | $2K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 359 | $2K |
| 93926 | <1% | 48 | $2K | |
| 95861 | <1% | 42 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 593 | $2K |
| 90756 | <1% | 81 | $2K | |
| 96127 | <1% | 382 | $2K | |
| 75716 | <1% | 12 | $1K | |
| 95992 | <1% | 265 | $1K | |
| 20550 | <1% | 21 | $1K | |
| 31575 | <1% | 15 | $1K | |
| 69210 | <1% | 36 | $1K | |
| 99406 | <1% | 123 | $1K | |
| 95117 | <1% | 106 | $1K | |
| 82962 | <1% | 1,003 | $1K | |
| 95911 | <1% | 12 | $995.90 | |
| 69200 | <1% | 13 | $953.80 | |
| 76536 | <1% | 23 | $871.31 | |
| 11720 | <1% | 14 | $821.34 | |
| 1160F | <1% | 9,630 | $711.62 | |
| 90746 | <1% | 12 | $689.04 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 418 | $670.01 |
| 93228 | <1% | 99 | $666.64 | |
| 94010 | <1% | 25 | $650.57 | |
| 96146 | <1% | 274 | $608.65 | |
| 3008F | <1% | 11,435 | $524.02 | |
| 1159F | <1% | 8,862 | $511.89 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 33 | $484.39 |
| 51784 | <1% | 49 | $457.19 | |
| 96133 | <1% | 12 | $431.40 | |
| 81025 | <1% | 166 | $365.80 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 40 | $316.61 |
| G2011 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | <1% | 12 | $249.69 |
| 90656 | <1% | 12 | $220.66 | |
| 90686 | <1% | 12 | $214.87 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 608 | $212.00 |
| 76870 | <1% | 13 | $190.86 | |
| 1033F | <1% | 1,075 | $156.53 | |
| 3079F | <1% | 2,144 | $135.07 | |
| 3078F | <1% | 8,034 | $124.16 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 79 | $114.33 |
| 1125F | <1% | 687 | $105.80 | |
| J3490 | Unclassified drugs | <1% | 734 | $104.80 |
| 99080 | <1% | 6,734 | $50.00 | |
| 93325 | <1% | 19 | $48.00 | |
| 51741 | <1% | 15 | $20.27 | |
| 81002 | <1% | 26 | $17.40 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 5,185 | $15.01 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 14 | $2.38 |
| 3074F | <1% | 7,893 | $2.28 | |
| 1126F | <1% | 1,106 | $0.06 | |
| 1034F | <1% | 40 | $0.05 | |
| 3075F | <1% | 1,039 | $0.05 | |
| 2028F | <1% | 54 | $0.04 | |
| 3725F | <1% | 2,586 | $0.02 | |
| 91301 | <1% | 169 | $0.01 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 491 | $0.00 |
| 1170F | 0% | 522 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 227 | $0.00 |
| 90688 | 0% | 18 | $0.00 | |
| 3080F | 0% | 30 | $0.00 | |
| 1090F | 0% | 749 | $0.00 | |
| 3077F | 0% | 1,035 | $0.00 | |
| 0518F | 0% | 650 | $0.00 | |
| G8539 | Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment | 0% | 48 | $0.00 |
| 87400 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDANESHVAR, SHAHRIAR (CEO)
| Provider | Location | Paid |
|---|---|---|
| Avicenna Asc INC. | Bronx, NY | $6.35M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.